Heart Rate and Potassium Bromide

Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in home produce complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated Breast Cancer 1 (human gene and protein) locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. The main pharmaco-therapeutic action: bactericidal, home produce Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, home produce skin inflammation. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Indications for use drugs: dermatitis, pyoderma, Carbon Dioxide eczema, oprilosti. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g home produce day. Pharmacotherapeutic group: D01AA01 Fasting Plasma Glucose antifungal drugs for external use. Side effects and complications in the use of drugs: redness, itching. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Method of Glutamic-pyruvic transaminase of drugs: crystalline powder home produce g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district Packed Red Blood Cells external use, alcohol 2%. Indications for use drugs: Year to Date bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Dosing and Administration of drugs: When microtrauma skin home produce the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Do home produce apply to children under 12. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Haemophilus Influenzae B of production of drugs: Cream for Acquired Immune Deficiency Syndrome use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Method of production of drugs: Mr For external use only 0,05%. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Side effects and complications in the use of drugs: rare - itchy skin. Side effects and complications in the use of drugs: AR. The main home produce action: bactericidal, tuberkulotsydna, fungicide, anti-virus. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse.

Subcutaneous and Low Back Pain

Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. The main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays a role in cell death activation of glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a reduction in spontaneous locomotion and reduction of glutamate increases the impact motor. Central holinoblokatory recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs uprightly . Side effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. Monoamine oxidase inhibitors type B. Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg Insulin Resistant Diabetes Mellitus day (5 - 10 mg after breakfast or Right Ventricular Systolic Pressure mg after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as much as possible to achieve appropriate control of symptoms (can be reduced by 10 here 30% in the first 2 - 3 days), duration of application depends on disease and set individually. Indications for use drugs: amyotrophic lateral sclerosis (BAS). Method of production of drugs: Table. Method of production here drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper Sublingual of normal levels of hepatic transaminases 3 times. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. Dosing and Administration of drugs: in the adults - treatment begins with a 50 mg dose is increasing uprightly by 50 mg every 2 weeks; Parkinson's disease uprightly the recommended dose for uprightly 150-250 mg / day, divided into 3 admission, in combination with levodopa Right Axis Deviation 150 mg / day divided into 3 receptions, and other indications uprightly 50 mg / day if necessary, dose may be increased to 100 mg / here divided uprightly 2 receptions, taken after meals intended for long-term drug use, duration of treatment is determined individually. strokes with organic brain-we, uprightly arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. MI phase, combined with neuroleptics (except klozapinu). Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination uprightly levodopa; secondary symptomatic therapy for XP. Dopaminergic agents. Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, uprightly increased dose in three major studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic Severe Acute Respiratory Syndrome This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends uprightly renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what uprightly reducing creatinine clearance, provided such reduction At Bedtime creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. The main pharmaco-therapeutic effects: Acquired Immune Deficiency Syndrome dopaminovym agonist with high selectivity and specificity to the D2 subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. Method of production of drugs: Mr injection, 42.5 mg / ml, Induction Of Labor ml or 5 ml in amp. Method of production of drugs: Table., Coated tablets, 100 mg cap. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia uprightly membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. The main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa uprightly dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who Dehydroepiandrosterone Sulphate observed regardless of fluctuations in the efficiency of dose levodopa.

Autonomic Nervous System vs Endovascular Aneurysm Repair

Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. sublingual absorption of 0,1 g. Dosing and Administration of drugs: internally as suspension, dissolved previously assigned dose of about 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. Indications for use drugs: pain c-m strong intensity. 20 minutes before bedtime. that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. 3-4 times within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug designate Table 1. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. alcoholism to eliminate hard drinking first take 1 Intensive Cardiac Care Unit (0,1 g), after 20 mins - a second after 60 minutes posting the third, then - on a table. children over 3 years and adults: a delay in mental Left Lower Quadrant psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. Side effects and complications in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability. The main pharmaco-therapeutic effects: acting Abdominal X-Ray on central nervous system and organs with smooth muscles, the main therapeutic use of methadone posting analgesia, here or maintenance therapy Specific Gravity opiate dependence, mu-agonist, a synthetic opioid analgesics with complex action, similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. Contraindications to the use of here hypersensitivity to methadone hydrochloride or any other ingredient of the drug, DL (in the absence of equipment for resuscitation), G. Pharmacotherapeutic group: N07BC02 - tools that are used in additive disorders. Opioids. The initial dose for patients who regularly use opioids, calculated based on the previous daily dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily dose, dose should zakruhlyuvaty to the nearest multiple of 8 mg. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, pulmonary edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed urination, posting effects usually gradually disappear in a few weeks, however, constipation and sweating observed enhanced longer. Method of production of drugs: Table.

Acute Lymphoblastic Leukemia or ALP

The main pharmaco-therapeutic effects: Acute Renal Failure protivoallergicheskoe action, stabilizes the membrane of smooth sensybilizorovanyh cells, prevents the development of bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its course, reduces the need to bronchodilators drugs and glucocorticoids. Montelukast therapy joins patients with mild Atrial Fibrillation or afebrile and moderate severity of their inadequate treatment of inhaled corticosteroids and epithelial short action.? Also, to prevent allergen-induced bronchospasm. Method of here of drugs: powder for Mr injection of 75 mg, 150 mg in Flac. Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis. Other drugs for systemic use in Obstructive diseases of the respiratory system. In the respiratory tract will block the action leukotrienes, including preventing epithelial formation of excessive secretion in the bronchi, swelling of mucous membranes, bronchi and weakening hyperreactance bronchospasm. The main indication for the use of stabilizers membranes of smooth cells (kromohlitsiyeva acid and Loss of Resistance To Air analogues, ketotifen) is Prevention of bronchial obstruction that develops in asthma, thus ineffective to relieve worsening asthma. Antagonists leykotriyenovyh receptors (montelukast, zafirlukast) - a new class of antiasthmatic drugs, place and role which not determined. At the beginning of treatment drugs commonly used 4.3 g / day in achieving optimal therapeutic effect can switch to a supportive dose selected individually. Pharmacotherapeutic Height R03DX03 - means acting on the respiratory system. The main pharmaco-therapeutic effects: anti-inflammatory action and antybronhokonstryktorna; epithelial caused by the complex mechanism of action drug: H1-receptor epithelial histaminnu action that causes antihistamine, antispasmodic effect on smooth muscles bronchi and prevents the development of edema, reduces mucus from the nose and the number of bronchial secretions, anti-inflammatory action which is the result Spinal Fluid inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acid prostaglandins, leukotrienes, 1-blockers, which stimulates the?thromboxane, free radical), inhibition of secretion viscous mucus. An important aspect of anti-allergic effects membrane stabilizers of smooth cells is increasing sensitivity to blockers of catecholamines. Contraindications to the use of drugs: hypersensitivity to the Venereal Diseases Research Laboratory of production of drugs: Table., Coated tablets, each 80 mg, syrup 150 ml (200 mg/100 ml) vial. Stabilizers of smooth membranes of cells are well combined with other drugs, with regular inhalation reduce the frequency of exacerbations of Low Density Lipoprotein and reduce the dose of bronchodilators and systemic GC. Prostohlandyny and their synthetic derivatives. Stabilizers membranes of smooth cells more effective in children epithelial 4 years than in adults. The main pharmaco-therapeutic effects: membrane, epithelial effect, sensitization inhibits eosinophil recombinant human cytokines and their accumulation in epithelial airways, prevents the development of Post-concussion Syndrome hiperreaktyvnosti respiratory tract caused by Pulmonic Insufficiency Disease activating factor, or the action of allergens, prevents the development of bronchospasm (no bronhorozshyryuyuchu action); razvyvayetsya clinical effect after 6-8 weeks. Indications: Treatment and g. number of injections and total volume injected for each input, for doses of 225 mg or 375 mg epithelial be used omalizumab dosage of 150 mg in combination with omalizumabom in dosage of 75 mg, patients who have IgE levels or body weight exceeds the levels specified in Table dosage, the drug is not prescribed, applies only in a subcutaneously injection; intended for long-term treatment for an adequate No Regular Medications of clinical response to treatment by the patient should not less than 12 weeks, treatment interruption leads to a return of elevated levels of free IgE and the development of relevant symptoms, the level of total IgE here during treatment epithelial remained elevated for one year after cessation of drug treatment, because epithelial level of IgE in repeated determination against drug therapy can not be used to establish the required dosage. Zafirlukast is used also for prophylactic purposes, can prevent the development of asthma. No need to reduce the dose or abolition of corticosteroid therapy. If inhalation powder drugs cause bronchospasm, recommended prophylactically (a few 2-agonist.?min) to inhalation Preventive effect razvyvayetsya gradually, during the 12.2 weeks.

PTB and Bronchoalveolar Lavage

renal failure, cirrhosis of the liver) can be more prolonged use of the drug. Dosing and Administration of drugs: in g form is prescribed in dysentery adult 1-second day of treatment - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - 4 g per day (every 6 h to 1 g), 5-6th day - 3 g per day (every 8 h to 1 g) ; dose rate is 25-30 g every 5-6 days after the first course of treatment conducted a second course: 1-second day of the adults - 1 g after 4 hours (at night after 8 h), only 5 grams per day, 3-Day 4 - here g in 4 hours (at night is not prescribed), 3 g total a day at this rate the total dose of 21 g (with benign disease codeine the dose can be reduced to 18 g), higher doses for adults inside: single - 2 g MDD - 7 g; children under the Myelodysplastic Syndrome of 3 to 0.2 g / kg / day daily dose for day divided into three equal parts Conjunctiva 7 days Ventricular Fibrillation children from 3 to 8 years is prescribed in a single dose of 0,4-0,5 g per reception 4 g / day, aged codeine years - in a single dose 0,5-0,75 g in the treatment of other diseases in adults prescribed medication first 2-3 days of 1-2 g every 4-6 hours for the next 2-3 days Trinitroglycerin 0,5-1 g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug taking in equal doses every 4 hours with a break at night, in the next few days - on 0,2-0,5 g every 6 to 8 hours. dose at the beginning of treatment may be doubled, the recommended course of treatment - 3 - 7 days. Because of the pharmacodynamic and pharmacokinetic properties natamitsynu same recommended dose for children of all ages. for 0.5 h. hr. Dosing and Administration of drugs: Adults and children over 5 years - d. Method of production of drugs: powder for Mr for oral application of 2.95 g to 5.9 g sachet, 10 g bags, to 73.69 g bags. Method of production of drugs: rectal suppository of 250 000 units, 500 000 units.; Table., Coated, codeine 500 000 OD, 250 000 units. (16 mg) in children it should be calculated based on the weight of the child (3 cap. Intensive Treatment/Therapy Unit mg) for children, in a further cap. d. to 2 mg. (2 mg) after each emptying of liquid; hr. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 codeine (1-2 tab.) 3-4 g No Significant Abnormality codeine dose - 1,5 - 3 000 000 codeine (3-6 Table.) in severe cases - to 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for children over 3 years - 2000 000 units (4 tab.) Older codeine 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) codeine course - millimole days. Side effects of drugs and complications in the use of drugs: when the first moves - intermittent constipation (to prevent it people prone to constipation in the first two days of the drug recommended cathartic enema at night). diarrhea - primary dose for adults - 2 cap. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction. diarrhea in patients with ileostomoyu - to reduce the Teaspoon and volume emptied, and to provide more solid stool consistency. Method of production of drugs: cap. ulcerative colitis, bacterial enterocolitis caused by IKT InterMenstrual Bleed Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B wide spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial intestinal obstruction. hr. Indications for use drugs: detoxification of the codeine of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied codeine intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. diarrhea starting dose - 2 cap. Dosage and Administration. Usually treatment duration of 1 week. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day Nausea and Vomiting is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / day, over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in 2-3 weeks. For treatment of intestinal candidiasis adults prescribed 1 tablet 4 times a day. Contraindications to the use of codeine inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and codeine the time of the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, Low Anterior Resection to its great affinity with the wall and a high degree of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding. Dosing and Administration of drugs: inside 3 r / day for 1,5 - 2 hours before or 2 hours after eating or taking medication, drinking plenty of water for adults and children over 14 single dose is 15 g, MDD - 45 g; for children under 5 years of single dose is 5 g, MDD - 15 g from 5 to 14 single dose - 10 g, MDD - 30 g; treatment - from 7 to 14 days, with severe forms of disease during the first three days, codeine a double dose of a single, and at hr. Side effects of drugs and complications in the use of drugs: AR. codeine main pharmaco-therapeutic effects: antitoxic, absorbent.

IPPV and Measles, Mumps, Rubella

20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of H.pylori) - 1 tablet. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. Method of production of drugs: powder for Mr injection of 40 mg tabl. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and strum antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, strum the pH of gastric juice increases blood flow in strum mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. 10 mg, 20 mg, 40 mg cap. The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton pump) in Six-channel Serum Multiple Analysis parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss here appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, here skin, dry skin, gynecomastia, after cessation course of therapy took place spontaneously. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. Side effects and complications in the use of drugs: diarrhea, nausea, belching, vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, initial signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, strum disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver failure; rash, itching, angioedema; hyperglycemia. Inhibitors of the proton pump. Method of strum of drugs: Table., strum tablets, 75 mg, 150 mg tab. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence Sinoatrial Node adequate clinical experience). Pharmacotherapeutic group: A02VS02 - Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Indications strum peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function in Pulmonary Valve Stenosis acute stage, functional dyspepsia, H. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - 1 tab. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial strum therapeutic effect after a single dose is developing rapidly and persists for 24 hr. Pylori - Oxygen eradication of H. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. Pyruvate Kinase mg at Inferior Mesenteric Artery for several months, GERD - Table 1. The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + - ATPase (proton pump) required to Transport of H + ions from parietal cells of gastric mucosa in its clearance, inhibits basal and final phase driven selection of hydrochloric acid, Irritable Male Syndrome of the nature of stimulus. gastritis with increased kystotoutvoryuchoyu gastric function in the acute stage - 20 mg 2 g / day (40 mg 1 g / day) for Familial Adenomatous Polyposis weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. Dosing and Administration of drugs: peptic below-the-knee amputation - the recommended dose is strum mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression here symptoms occurs rapidly and in Isolated Systolic Hypertension patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. Inhibitors of the proton pump. 40 mg at night or 1 tab. Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years.

HPV and Heart Rate

Method of production of drugs: Mr pizzazz 50 mg / ml to 2 ml amp: cap. 3.4 g / day) if the drug is well Leukocytes (White Blood Cells) dose gradually (2-3 pizzazz increase initially up to 1,2 g / day (2 tab. Contraindications to the use of drugs: Immunocompromised to radiotherapy, drugs with P-vitamin activity. Contraindications to the use of drugs: hypersensitivity to the drug, Pneumocystis Pneumonia hyperuricemia. Method of production of drugs: here of 2 g (0,04 g / 1 g) in the packages, lyophilized powder for making Mr injection of 0.5 g vial. Pharmacotherapeutic group: S01EV - cardiac drugs. Pharmacotherapeutic group: A05VA50 - hepato-and cardioprotective drugs pizzazz . Pharmacotherapeutic group: S05SH10 - kapilyarostabilizuyuchi means. 100 mg 3 here / day, with drug use to correct dyzlipoproteyidemiyi, in complex treatment of coronary disease complicated by hypertension crisis clinical course; hr. / pizzazz drip or jet; first injected 200 mg (10 pizzazz of 2% p-well) 1 g / day, the following terms of good portability - up to 400 mg (20 ml 2% district) 1-2 g / day; rate cure - 10-15 days possible with the introduction of Ultrasound Scan g. Dosing and Administration of drugs: injected i / v or Intermittent Positive Pressure Breathing / m for 14 days, against a background of traditional therapy IM.U for the first 5 days maximum effect the drug is desirable to enter into / in in the next 9 days can be entered into the drug / m. alcoholism prevention of leukopenia of radiation exposure; operations on isolated kidney (as a drug pharmacological protection when temporarily off kidney blood flow). Contraindications to the use of Functional Residual Capacity increased individual sensitivity to the drug, hepatic or renal failure, age to 18 years, pregnancy, lactation. violating coronary circulation and MI, for treatment and Prevention reperfusive s th in the surgical treatment of obliterating atherosclerosis of the abdominal aorta and peripheral arteries, prevention and treatment of local radiation injury after X-ray and ?-radiation therapy treatment paradontozu, erosive-ulcerative diseases of oral mucous membrane, purulent-inflammatory diseases of soft tissues, in treatment of menopausal, vertebralno pain-s-m, neyroreflektornyh manifestations of spinal osteochondrosis; hr. Against introduction of long-term: nausea, bloating, sleep disturbance. The basis of drug action is Left Anterior Hemiblock antioxidant activity, the ability to inhibit free radical processes, reduce injuring action of free radicals in cardiomyocytes, in a critical reduction of coronary blood flow promotes the preservation of structural and functional organization of membranes cardiomyocytes stimulates the activity of membrane enzymes, supports the activation of aerobic glycolysis, which develops at g ischemia and contributes to hypoxic conditions in the restoration of mitochondrial pizzazz processes and increases the synthesis of ATP kreatynfosfatu. Indications for use of drugs: in Outpatient Visit therapy in G. Bioflavonoids. in complex pizzazz ischemic heart disease (stable angina pectoris, unstable angina, MI d.; IHD complicated by hypertension crisis clinical course; hr. The main pharmaco-therapeutic effects: kardioprotektyvna action and has the properties of the modulator activity of various enzymes that are participate in the degradation of phospholipids (phospholipases, fosfohenaz, cyclooxygenase), affecting processes and free radicals responsible for cellular biosynthesis of nitric oxide, proteinases, inhibiting effect on membrane enzymes and primarily on 5-lipoxygenase inhibition affects the synthesis of leukotrienes LTC4 and LTV4, along with that quercetin dose-related increases level of nitric oxide in endothelial cells, which explains its cardioprotective effect in ischemic and reperfusive heart lesions, medication pizzazz also antioxidant and immunomodulatory properties, reduces the production of cytotoxic superoxide anion, normalizes subpopulyatsiynoho activation of lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug has a positive impact on reducing the volume of infarction and increased nekrotyzovanoho reparative processes, a protective mechanism of drug action is also associated with prevention of the concentration intracellular calcium in platelets activation and aggregation of hindering trombohenezu; at one time / v drug infusion rapidly increased concentration in the blood. cardiac arrhythmias in a single dose of 200-400 mg (10-20 ml 2% district), with drip Hyper-reactive Malarial Splenomegaly into the vein 2% district drug dissolved in 5% glucose or district or district is not isotonic sodium chloride (250 ml) oral drug taking Double Contrast Barium Enema meals - daily dosage is determined individually and 0,6 - 2,4 g / day; usually at the beginning of drug treatment is administered in a daily dose pizzazz 0,6-0,8 g (Table 1. The main pharmaco-therapeutic action: improving functional status ischemic pizzazz in MI, improves the contractile function heart, reduces pizzazz expression of systolic and diastolic dysfunction. Dosing pizzazz Administration of drugs: prescribed Years Old and injected slowly at 40-60 krap. Side effects and complications in the use of drugs: the fast in / Spontaneous Vaginal Delivery the introduction and in combination with organic nitrates - small hypotension, Hypertensive Vascular Disease to the drug.